ARV Supply Expected To Stabilise As Court Battle Ends

Bottles of antiretroviral drug
Bottles of antiretroviral drug

The supply of Anti Retroviral (ARV) drugs is expected to stabilise after government won a marathon court battle against one of the major suppliers, Portfolio Pharmaceuticals.

The company had cited irregularities in awarding of a tender for the supply of the drugs, after Portfolio Pharmaceuticals lost a significant share of the market to other players.

Following that, a lengthy court battle ensued, which had affected supply, with some patients receiving a weekly, rather than their monthly allocations.

Editor's Comment
Diamond deal demands transparency

Instead, it has sparked a storm of accusations, denials, and unresolved questions about the influence of De Beers on the nation’s politics. Former president Mokgweetsi Masisi’s claims that the diamond giants bankrolled his removal to dodge taxes – and that the new Umbrella for Democratic Change (UDC) government watered down a favourable diamond deal – are explosive matters. But without evidence, they risk becoming a toxic distraction from...

Have a Story? Send Us a tip
arrow up